- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
October 17th, 2007
Tampa's TransGenex names Lucas CEO, president
TransGenex Nanobiotech Inc. has named John E. Lucas CEO and president.
Formerly chairman and CEO of EpiCept Corp., Lucas has also had experience with startups.
TransGenex is developing novel nanoparticle platform technologies to diagnose and treat a number of diseases. The company licensed its patents from the University of South Florida.
|Related News Press|
Graphenea celebrates fifth anniversary April 27th, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Heat-Converting Material Patents Licensed April 8th, 2015
From tobacco to cyberwood March 31st, 2015
Dais Analytic Corporation Appoints Eliza Wang to Board of Directors: Company's Newest Director Brings Expertise in Commercial and Legal Matters Both in the United States and China; Joins on the Heels of Successful Business Development Trade Mission to China April 18th, 2015
Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015